Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with Royalty ...

Stifel analysts maintained a Hold rating on Procter & Gamble stock (NYSE:PG) with a steady price target of $161.00. The ...

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.

Stifel analyst Drew Crum raised the firm’s price target on Take-Two (TTWO) to $223 from $220 and keeps a Buy rating on the shares. The firm ...

Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...

Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...

Stifel downgrades cybersecurity stocks Rapid7 and Tenable to Hold, citing cautious stance on vulnerability management.

Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...